Journal of Pharmacovigilance and Drug Research

Skip to main content Skip to main navigation menu Skip to site footer

Announcements

Inviting manuscripts

2023-12-25

Dear Researchers,

"New Year Offer 2024"

JPADR successfully stepped into its 5th year of service. We invite manuscripts from you in the form of a research article/ review article/case report/ case series on adverse events associated with drug formulations. The submitted manuscripts will be peer-reviewed before their acceptance. We have waived the APC for the next two issues i.e. Volume 5 Issue No. 1 (March 2024) and 2 (June 2024). Hence, Authors can publish their articles for free. No article processing or publication charges.

Thank you

Current Issue

Vol 4 No 4 (2023): Journal of Pharmacovigilance and Drug Research

Volume 4 Issue 4 contains five articles. 1 review, 3 research, and 1 case report.

Published on December 01, 2023.

Published: 2023-12-01

Reviews

Pharmacovigilance in Nepal: Present Glance and Areas to Improve.

Roshan Giri, Aman Kumar Sah, Uday Bir Shahi

1-8
- PDF

Research articles

Analysis of drug-induced pancreatitis reports within the United States Food and Drug Administration and Veterans Health Administration Drug Event Reporting Systems

Kristen Wilhite, Jennifer Meyer Reid, Carrie Isaacs, Matthew Lane

9-15
- PDF
Knowledge, attitude, and practices regarding reporting of Adverse Events Following Immunization (AEFI) among healthcare professionals

Girish Hiremath, Jyothi R, Akash Gadgade, Nikita Sudhir Kulgod, Ashwini M Kambalyal, Bhoomi Chirag Bagadia, Jhilli Basu, Udaya K

16-23
- PDF
Knowledge and practice of Iraqi community pharmacists on national adverse events reporting and review of the constraints of drug safety reporting

Samer Shukur Mohammed, Wael Waleed Musatafa, Manal Mohammed Younus

24-30
- PDF

Case reports

Methotrexate overdose induced acute kidney injury and pancytopenia: a case report

Gunjan Gayen, Tapas Bera, Abhik Saha, Ramtanu Bandyopadhyay, Sagnik Chakraborty

31-33
- PDF

View All Issues

The Journal of Pharmacovigilance and Drug Research (JPADR) is the official publication of the Global Pharmacovigilance Society. This is an international, open-access, and peer-reviewed scientific journal. It focuses on pharmacovigilance studies and their associated topics such as adverse drug reactions, drug clinical trials, drug effectiveness and efficacy, drug risk management, as well as all aspects related to the safe use of drugs.

Authors can submit manuscripts related to

1. Pharmacovigilance

2. Materiovigilance/Technovigilance

3. Ecopharmacovigilance

4. Ayurvedic drugs safety

5. Pharmacology

6. Computer-aided drug design

7. Formulation of pharmaceutical research and development

8. Animal Study

9. Preclinical trials

10. Clinical trials

11. Biotechnology

12. Pharmacoepidemiology

13. Ergonomics

14. Newly identified drug

15. Haemovigilance

16. Artificial Intelligence and Machine Learning in Pharmaceutical Drug Development

The JPADR is oriented to researchers, professors, students, and practitioners from both the pharmaceutical industry sector, as well as the wide range of health and medicine arenas. The journal’s objective is to establish a formal platform for communicating the research results on pharmacovigilance.

An official publication of Global Pharmacovigilance Society

“A goal towards patient safety and drug safety”

Abstracting and Indexing: ICMJE, Sherpa Romeo, National Digital Library of India, Google Scholar, Geneva foundation for medical education and research, J-Gate, ResearchBib, EuroPub, Zenodo, OpenAIRE, and more.

Contact: editor@jpadr.com/ editor.jpadr@gmail.com

Editor-in-Chief: Dr.Chinmaya Mahapatra, M.Pharm, Ph D.